Screener
Sarepta Therapeutics, Inc. SRPT Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Sarepta Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
FAQ
- What is Sarepta Therapeutics, Inc.'s net margin?
- Sarepta Therapeutics, Inc. (SRPT) reported net margin of -6.9% in Q2 2026.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s net margin?
- Over 4 years (2020 to 2025), Sarepta Therapeutics, Inc.'s net margin has grown at a -25.0% compound annual growth rate (CAGR), from -102.6% to -32.5%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Sarepta Therapeutics, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude